Tau Protein Phosphorylated at Threonine-231 Is Expressed Abundantly in the Cerebellum in Prion Encephalopathies
Gómez-López, V. M., Viramontes-Pintos, A., Ontiveros-Torres, M. A., Garcés-Ramírez, L., De La Cruz-López, F., Villanueva-Fierro, I., Bravo-Muñoz, M., Harrington, C., Martínez-Robles, S., Yescas, P., Guadarrama-Ortíz, P., Hernandes-Alejandro, M., Montiel-Sosa, J. F., Pacheco-Herrero, M., Luna-Muñoz, J.
Journal of Alzheimer's Disease, vol. 81, no. 2, pp. 769-785
Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update
Okoliegbe, I., Hijazi, K., Cooper, K., Ironside, C., Gould, I.
Antimicrobial Agents and Chemotherapy, vol. 65, no. 6, e02483-20
Positive and negative inflammatory markers for falls and sarcopaenia in the Malaysian Elders Longitudinal Research study - A five-year prospective study
Hashim, N. N. A., Mat, S., Myint, P. K., Delibegovic, M., Kioh, S. H., Pin, T. M.
Australasian journal on ageing, vol. 40, no. S1, pp. 1-2
Contributions to Journals: Abstracts
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Soiza, R., Macleod, M., Cooper, J.
Safety assessment of titanium dioxide (E171) as a food additive
Younes, M., Aquilina, G., Castle, L., Engel, K., Fowler, P., Frutos Fernandez, M. J., Fürst, P., Gundert-Remy, U., Gürtler, R., Husøy, T., Manco, M., Mennes, W., Moldeus, P., Passamonti, S., Shah, R., Waalkens-Berendsen, I., Wölfle, D., Corsini, E., Cubadda, F., De Groot, D., FitzGerald, R., Gunnare, S., Gutleb, A. C., Mast, J., Mortensen, A., Oomen, A., Piersma, A., Plichta, V., Ulbrich, B., Van Loveren, H., Benford, D., Bignami, M., Bolognesi, C., Crebelli, R., Dusinska, M., Marcon, F., Nielsen, E., Schlatter, J., Vleminckx, C., Barmaz, S., Carfí, M., Civitella, C., Giarola, A., Rincon, A. M., Serafimova, R., Smeraldi, C., Tarazona, J., Tard, A., Wright, M., EFSA Panel on Food Additives and Flavourings (FAF)
Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials: A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study
Zhang, Q., Werys, K., Popescu, I. A., Biasiolli, L., Ntusi, N. A. B., Desai, M., Zimmerman, S. L., Shah, D. J., Autry, K., Kim, B., Kim, H. W., Jenista, E. R., Huber, S., White, J. A., McCann, G. P., Mohiddin, S. A., Boubertakh, R., Chiribiri, A., Newby, D., Prasad, S., Radjenovic, A., Dawson, D., Schulz-Menger, J., Mahrholdt, H., Carbone, I., Rimoldi, O., Colagrande, S., Calistri, L., Michels, M., Hofman, M. B. M., Anderson, L., Broberg, C., Andrew, F., Sanz, J., Bucciarelli-Ducci, C., Chow, K., Higgins, D., Broadbent, D. A., Semple, S., Hafyane, T., Wormleighton, J., Salerno, M., He, T., Plein, S., Kwong, R. Y., Jerosch-Herold, M., Kramer, C. M., Neubauer, S., Ferreira, V. M., Piechnik, S. K., HCMR
International Journal of Cardiology, vol. 330, pp. 251-258